• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Memantine Teva
    / Teva


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    56 x 10 mg

    not in the basket chart 83518 13634

    Related information


    Dosage

    The usual dosage:
    Adults and the elderly:  20 mg per day.
    Initial dosage: In order to reduce the risk of side effects, the dosage should be gradually increased, as per the following program:
    Week 1- 5 mg per day (half a tablet)
    Week 2- 10 mg per day (one tablet)
    Week 3- 15 mg per day (one and a half tablets)
    Week 4 and on 20 mg per day (2 tablets)
    The initial dosage is half a tablet per day for the first week. In the second week, one tablet per day. In the third week, one and a half tablets per day. From the fourth week and on, two tablets per day.
    Dosage for patients with moderate kidney function: According to the doctor’s recommendation. In addition, kidney function monitoring tests should be performed.
    Do not exceed the recommended dose.
    Instructions for use of the medicine: Swallow the tablet with a little water. The tablet can be halved on the score line. Take the medicine every day at the same time.
    Tests and follow-up: During the course of treatment with this medicine, kidney function tests should be performed.


    Indications

    Treatment of patients with moderate to severe Alzheimer’s disease.


    Contra-Indications

    Known hypersensitivity to the active ingredient or to any component of the product. Pregnancy and lactation. Patients with severe renal failure. Combination with amantadine, ketamine, dextromethorphan, and other drugs belonging to N-methyl-D-aspartate (NMDA) antagonists.


    Special Precautions

    See prescribing information for full details.


    Side Effects

    See prescribing information for full details.


    Drug interactions

    Combination with amantadine, ketamine, dextromethorphan, and other drugs belonging to N-methyl-D-aspartate (NMDA) antagonists.
    See prescribing information for full details.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE